ClinicalTrials.Veeva

Menu

Scleral Buckling for Retinal Detachment Prevention in Genetically Confirmed Stickler Syndrome (STL-DR-PREV)

A

Assistance Publique - Hôpitaux de Paris

Status and phase

Not yet enrolling
Phase 2

Conditions

Stickler Syndrome

Treatments

Procedure: Encircling scleral buckle surgical procedure

Study type

Interventional

Funder types

Other

Identifiers

NCT04465188
P160948J
2018-A01081-54 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine whether a scleral buckling surgical procedure performed on fellow eyes of patients with genetically confirmed Stickler syndrome can prevent the occurrence retinal detachment and/or severe vision loss of the study eye.

Full description

Stickler syndrome (STL) is a genetic disease affecting several organs. However the major risk is represented by the development of retinal detachment (RD). Up to 80% of patients present a RD and 25% to 80% have sequential bilateral RD. The surgical outcome of RD in this population is worse than that of the general RD population mainly because of the severity at diagnosis and the high frequency and severity of postoperative complications. Prevention has therefore emerged as a therapeutic option for this identifiable high-risk group of patients. Prevention has been proposed especially for the fellow (contralateral) eye of patients having presented a RD in their first eye and often lost vision as a consequence of retinal detachment in the first eye.

The investigators hypothesize that a scleral buckling surgical procedure performed for the fellow eye of STL patients having recently presented a RD of the first eye could prevent the occurrence of bilateral RD and/or vision loss.

Stickler patients are regularly diagnosed and followed-up in referral centers mainly in the context of a recent retinal detachment. They are proposed genetic testing as part of the standard of care. Genetically confirmed Stickler patients having recently presented (<24 months) a retinal detachment and treated as part of the standard care are eligible for this study. During the usual follow-up visits performed for their recent first RD operation they will be informed and offered to participate in the "STL-DR-PREV study" for the prevention of RD of their fellow eye.

Patients in the intervention arm will undergo an encircling scleral buckle surgical procedure, which is a routine surgical procedure used for decades and still in use to treat RD that will be performed in the present study to prevent rather than to treat retinal detachment from a healthy eye of a patient having a genetically confirmed Stickler Syndrome.

Enrollment

40 estimated patients

Sex

All

Ages

5 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Genetically confirmed Stickler Syndrome
  • Aged 5 to 35
  • Recent retinal detachment in the non-study eye (<24 months)
  • Signed informed consent to participate in the study
  • Sufficient patient cooperation to perform a complete ophthalmologic examination including a dilated fundus examination

Exclusion criteria

  • Any type of previous prevention (laser, cryotherapy, scleral buckle) for the study eye
  • Subclinical retinal rhegmatogenous detachment in the study eye.
  • Any other ocular disease unrelated to Stickler syndrome significantly affecting visual acuity (ETDRS BCVA<20/400).
  • Contraindications to general anesthesia
  • Posterior vitreoretinal traction on optical coherence tomography
  • Intraoperative detection of one or more of the above-mentioned non-inclusion criteria

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Experimental arm
Experimental group
Description:
Surgical procedure to prevent retinal detachment in the unaffected eye
Treatment:
Procedure: Encircling scleral buckle surgical procedure
Control arm
No Intervention group
Description:
Standard procedure of clinical practice without any surgical procedure for the unaffected fellow eye.

Trial contacts and locations

1

Loading...

Central trial contact

Pierre-Raphael ROTHSCHILD, MD, Phd; Laetitia PEAUDECERF

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems